Literature DB >> 18396160

Intracellular delivery of acetyl-histone peptides inhibits native bromodomain-chromatin interactions and impairs mitotic progression.

Akira Nishiyama1, Kazuki Mochizuki, Florian Mueller, Tatiana Karpova, James G McNally, Keiko Ozato.   

Abstract

Bromodomains present in Brd4 and other chromatin proteins interact with acetylated histones to regulate transcription and cell growth. To study Brd4-chromatin interactions in vivo, histone H4 tail peptides were fused to a synthetic protein transduction domain (PTD) derived from the human immunodeficiency virus Tat and delivered into cultured cells. Acetyl-H4 peptides, but not unacetylated H4 peptides inhibited real time Brd4-chromatin interactions in living cells as assessed by fluorescence recovery after photobleaching assays. The acetyl-H4 peptides also inhibited an interaction of Brd4 with chromosomes during mitosis and reduced cell growth potential. Together, PTD-based delivery of histone tail peptides offers a novel means to study the mechanism and biological significance of bromodomain-chromatin interactions in vivo.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18396160      PMCID: PMC4120274          DOI: 10.1016/j.febslet.2008.03.044

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  14 in total

Review 1.  Bromodomain: an acetyl-lysine binding domain.

Authors:  Lei Zeng; Ming Ming Zhou
Journal:  FEBS Lett       Date:  2002-02-20       Impact factor: 4.124

Review 2.  Protein transduction technology.

Authors:  Jehangir S Wadia; Steven F Dowdy
Journal:  Curr Opin Biotechnol       Date:  2002-02       Impact factor: 9.740

Review 3.  Histone and chromatin cross-talk.

Authors:  Wolfgang Fischle; Yanming Wang; C David Allis
Journal:  Curr Opin Cell Biol       Date:  2003-04       Impact factor: 8.382

4.  Global nature of dynamic protein-chromatin interactions in vivo: three-dimensional genome scanning and dynamic interaction networks of chromatin proteins.

Authors:  Robert D Phair; Paola Scaffidi; Cem Elbi; Jaromíra Vecerová; Anup Dey; Keiko Ozato; David T Brown; Gordon Hager; Michael Bustin; Tom Misteli
Journal:  Mol Cell Biol       Date:  2004-07       Impact factor: 4.272

5.  Brd4 is required for recovery from antimicrotubule drug-induced mitotic arrest: preservation of acetylated chromatin.

Authors:  Akira Nishiyama; Anup Dey; Jun-Ichi Miyazaki; Keiko Ozato
Journal:  Mol Biol Cell       Date:  2005-12-07       Impact factor: 4.138

6.  The bromodomain protein Brd4 stimulates G1 gene transcription and promotes progression to S phase.

Authors:  Kazuki Mochizuki; Akira Nishiyama; Moon Kyoo Jang; Anup Dey; Anu Ghosh; Tomohiko Tamura; Hiroko Natsume; Hongjie Yao; Keiko Ozato
Journal:  J Biol Chem       Date:  2008-01-27       Impact factor: 5.157

7.  A two-photon FRAP analysis of the cytoskeleton dynamics in the microvilli of intestinal cells.

Authors:  François Waharte; Claire M Brown; Sylvie Coscoy; Evelyne Coudrier; François Amblard
Journal:  Biophys J       Date:  2004-12-13       Impact factor: 4.033

8.  Synthetic protein transduction domains: enhanced transduction potential in vitro and in vivo.

Authors:  A Ho; S R Schwarze; S J Mermelstein; G Waksman; S F Dowdy
Journal:  Cancer Res       Date:  2001-01-15       Impact factor: 12.701

Review 9.  The double bromodomain-containing chromatin adaptor Brd4 and transcriptional regulation.

Authors:  Shwu-Yuan Wu; Cheng-Ming Chiang
Journal:  J Biol Chem       Date:  2007-02-28       Impact factor: 5.157

10.  The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: peptoid molecular transporters.

Authors:  P A Wender; D J Mitchell; K Pattabiraman; E T Pelkey; L Steinman; J B Rothbard
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-21       Impact factor: 11.205

View more
  8 in total

1.  Brd4 marks select genes on mitotic chromatin and directs postmitotic transcription.

Authors:  Anup Dey; Akira Nishiyama; Tatiana Karpova; James McNally; Keiko Ozato
Journal:  Mol Biol Cell       Date:  2009-10-07       Impact factor: 4.138

2.  BRD4 coordinates recruitment of pause release factor P-TEFb and the pausing complex NELF/DSIF to regulate transcription elongation of interferon-stimulated genes.

Authors:  Mira C Patel; Maxime Debrosse; Matthew Smith; Anup Dey; Walter Huynh; Naoyuki Sarai; Tom D Heightman; Tomohiko Tamura; Keiko Ozato
Journal:  Mol Cell Biol       Date:  2013-04-15       Impact factor: 4.272

3.  BRD4 Couples NF-κB/RelA with Airway Inflammation and the IRF-RIG-I Amplification Loop in Respiratory Syncytial Virus Infection.

Authors:  Bing Tian; Jun Yang; Yingxin Zhao; Teodora Ivanciuc; Hong Sun; Roberto P Garofalo; Allan R Brasier
Journal:  J Virol       Date:  2017-02-28       Impact factor: 5.103

4.  Monitoring dynamic binding of chromatin proteins in vivo by fluorescence recovery after photobleaching.

Authors:  Florian Mueller; Tatiana S Karpova; Davide Mazza; James G McNally
Journal:  Methods Mol Biol       Date:  2012

5.  Chemical and biological tools for the preparation of modified histone proteins.

Authors:  Cecil J Howard; Ruixuan R Yu; Miranda L Gardner; John C Shimko; Jennifer J Ottesen
Journal:  Top Curr Chem       Date:  2015

6.  Suppression of the antiviral response by an influenza histone mimic.

Authors:  Ivan Marazzi; Jessica S Y Ho; Jaehoon Kim; Balaji Manicassamy; Scott Dewell; Randy A Albrecht; Chris W Seibert; Uwe Schaefer; Kate L Jeffrey; Rab K Prinjha; Kevin Lee; Adolfo García-Sastre; Robert G Roeder; Alexander Tarakhovsky
Journal:  Nature       Date:  2012-03-14       Impact factor: 49.962

7.  Control of inducible gene expression by signal-dependent transcriptional elongation.

Authors:  Diana C Hargreaves; Tiffany Horng; Ruslan Medzhitov
Journal:  Cell       Date:  2009-07-10       Impact factor: 41.582

8.  Bromodomain-Containing Protein BRD4 Is Hyperphosphorylated in Mitosis.

Authors:  Ranran Wang; June F Yang; Flora Ho; Erle S Robertson; Jianxin You
Journal:  Cancers (Basel)       Date:  2020-06-20       Impact factor: 6.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.